MARCIA BINION: Open Payments
NPI 1477056943 · FORT LAUDERDALE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,878 in 213 payments from 14 companies in 2025. Trend: 2023 $3,260 · 2024 $4,690 · 2025 $4,878
Food & beverage: $4,878
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 56 | $1,044 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 38 | $854 |
| Janssen Pharmaceuticals, Inc | 26 | $611 |
| Vanda Pharmaceuticals Inc. | 18 | $440 |
| Neurocrine BioSciences, Inc. | 23 | $414 |
| Axsome Therapeutics, Inc. | 7 | $347 |
| Alkermes, Inc. | 15 | $335 |
| ABBVIE INC. | 14 | $268 |
| Janssen Scientific Affairs, LLC | 2 | $172 |
| Otsuka America Pharmaceutical, Inc. | 8 | $140 |
Products named: CAPLYTA, INVEGA SUSTENNA, UZEDY, INGREZZA, HETLIOZ, AUSTEDO XR, Auvelity, VRAYLAR.
Industry payments across FL — which companies pay providers there.
